IP Verse

Androgen Receptor Modulator And Uses Thereof - EP2945628B1

PatentPatent Analysis

EP2945628

ARAGON PHARMACEUTICALS
Application Number
EP14701865A
Filing Date
Jan 9, 2014
Status
Revoked
Sep 24, 2021
Grant Date
Apr 15, 2020
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3226841B1
EP3226843B1
EP3533792B1

Bibliography

The patent EP2945628B1 was granted to Aragon Pharmaceuticals on Apr 15, 2020 following the initial filing on Jan 9, 2014 under the application number EP14701865A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

GENERICS UKJan 15, 2021ADMISSIBLE
MAIWALDJan 15, 2021ADMISSIBLE
SYNTHONJan 15, 2021ADMISSIBLE
TEVA PHARMACEUTICALSJan 15, 2021ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents